| 202.18 0.56 (0.28%) | 02-12 19:48 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 274.2  |
1-year : | 301.61 |
| Resists | First : | 234.76 |
Second : | 258.23 |
| Pivot price | 219.06 |
|||
| Supports | First : | 196.8 |
Second : | 163.73 |
| MAs | MA(5) : | 204.16 |
MA(20) : | 225.01 |
| MA(100) : | 242.77 |
MA(250) : | 251.13 |
|
| MACD | MACD : | -9.3 |
Signal : | -6.5 |
| %K %D | K(14,3) : | 4.2  |
D(3) : | 2.5 |
| RSI | RSI(14): 23.4 |
|||
| 52-week | High : | 281.7 | Low : | 196.8 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ DHR ] has closed above bottom band by 23.8%. Bollinger Bands are 182.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 204.19 - 205.33 | 205.33 - 206.38 |
| Low: | 193.8 - 195.29 | 195.29 - 196.65 |
| Close: | 200 - 202.18 | 202.18 - 204.18 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Wed, 12 Feb 2025
Danaher's Options Frenzy: What You Need to Know - Benzinga
Wed, 12 Feb 2025
DHR Factor-Based Stock Analysis - Nasdaq
Wed, 12 Feb 2025
Is Danaher Corporation (DHR) The Best Manufacturing Stock To Buy Now? - Insider Monkey
Wed, 12 Feb 2025
Why Danaher Corporation (DHR) is the Best Medical Device Stock to Buy - Insider Monkey
Wed, 12 Feb 2025
Danaher Co. (NYSE:DHR) Shares Purchased by Channing Global Advisors LLC - MarketBeat
Wed, 12 Feb 2025
Capital Advisors Inc. OK Reduces Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 719 (M) |
| Shares Float | 642 (M) |
| Held by Insiders | 11 (%) |
| Held by Institutions | 81.5 (%) |
| Shares Short | 6,130 (K) |
| Shares Short P.Month | 5,730 (K) |
| EPS | 5.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 71.02 |
| Profit Margin | 16.3 % |
| Operating Margin | 20.3 % |
| Return on Assets (ttm) | 3.8 % |
| Return on Equity (ttm) | 7.5 % |
| Qtrly Rev. Growth | 3 % |
| Gross Profit (p.s.) | 19.77 |
| Sales Per Share | 33.01 |
| EBITDA (p.s.) | 10.44 |
| Qtrly Earnings Growth | -26 % |
| Operating Cash Flow | 6,290 (M) |
| Levered Free Cash Flow | 5,170 (M) |
| PE Ratio | 38.29 |
| PEG Ratio | 0 |
| Price to Book value | 2.84 |
| Price to Sales | 6.12 |
| Price to Cash Flow | 23.11 |
| Dividend | 0.27 |
| Forward Dividend | 0 |
| Dividend Yield | 0.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|